De Witte Jan
- SEC CIK
- 0001776929
In the past year, 2 open-market sale filings worth $645.9K and no purchases.
Current role at each company
- RMD Resmed IncDirectoras of Nov 26, 2025
- IART Integra Lifesciences Holdings CorpPresident & CEOas of Nov 4, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $645.9K
- 2 filings
- Net
- −$645.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists De Witte Jan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RMD Resmed Inc
Director5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2024 (view filing) | May 15 | 7 days | De Witte JanDirector | SSaleReMed Common Stock | −360 | $218.29 | −$78.6K | −4.6%7.52K after | Amended10b5-1 |
| Nov 14, 2024 (view filing) | Nov 12 | 2 days | De Witte JanDirector | SSaleReMed Common Stock | −796 | $248.81 | −$198.1K | −10.6%6.72K after | 10b5-1 |
| May 22, 2025 (view filing) | May 20 | 2 days | De Witte JanDirector | SSaleReMed Common Stock | −2.00K | $243.47 | −$486.9K | −25.6%5.81K after | 10b5-1 |
| Nov 13, 2025 (view filing) | Nov 11 | 2 days | De Witte JanDirector | SSaleReMed Common Stock | −487 | $250.25 | −$121.9K | −8.4%5.32K after | 10b5-1 |
| Nov 26, 2025 (view filing) | Nov 25 | 1 day | De Witte JanDirector | SSaleReMed Common Stock | −2.06K | $255.00 | −$524.0K | −32.5%4.26K after | 10b5-1 |
IART Integra Lifesciences Holdings Corp
President & CEO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2023 (view filing) | Jun 1 | 1 day | De Witte JanPresident & CEO | PPurchase | +7.79K | $38.50 | +$300.0K | +155.7%12.8K after |